1. Home
  2. EXK vs IDYA Comparison

EXK vs IDYA Comparison

Compare EXK & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Endeavour Silver Corporation (Canada)

EXK

Endeavour Silver Corporation (Canada)

HOLD

Current Price

$11.34

Market Cap

3.5B

ML Signal

HOLD

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

HOLD

Current Price

$32.17

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EXK
IDYA
Founded
1981
2015
Country
Canada
United States
Employees
N/A
N/A
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
2.9B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
EXK
IDYA
Price
$11.34
$32.17
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
14
Target Price
$13.31
$49.67
AVG Volume (30 Days)
17.4M
858.2K
Earning Date
03-10-2026
02-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$337,137,000.00
$214,834,000.00
Revenue This Year
$111.57
$2,688.43
Revenue Next Year
$64.09
N/A
P/E Ratio
N/A
N/A
Revenue Growth
49.22
5377.66
52 Week Low
$2.95
$13.45
52 Week High
$15.15
$39.28

Technical Indicators

Market Signals
Indicator
EXK
IDYA
Relative Strength Index (RSI) 47.57 43.58
Support Level $10.40 $31.54
Resistance Level $12.06 $34.66
Average True Range (ATR) 0.98 1.39
MACD -0.34 -0.32
Stochastic Oscillator 13.47 25.17

Price Performance

Historical Comparison
EXK
IDYA

About EXK Endeavour Silver Corporation (Canada)

Endeavour Silver Corp is a Canadian mineral company engaged in the evaluation, acquisition, exploration, development, and exploitation of precious metal properties in Mexico and Chile. The Company has two operating mining segments which are located in Mexico, Guanacevi and Bolanitos. The company has one development project in Mexico, Terronera, as well as Exploration and Corporate segments. The Exploration segment consists of projects in the exploration and evaluation phases in Mexico, Chile, and the USA.

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

Share on Social Networks: